World's Best Scientists 2026 revealed!
Pasquale Ferrante

Pasquale Ferrante

D-Index & Metrics

Immunology

D-Index
57
Citations
8897
World Ranking
3654
National Ranking
150

Pasquale Ferrante publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pasquale Ferrante sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 292 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pasquale Ferrante D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pasquale Ferrante sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pasquale Ferrante is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, with a particular focus on infectious diseases, oncology, epidemiology, public health, environmental and occupational health, and surgery.

The scientist has published research covering multiple specific topics, including:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Polyomavirus and related diseases
  • Research on Leishmaniasis Studies
  • Chromosomal and Genetic Variations
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts

Among the recent papers authored or co-authored by Pasquale Ferrante are:

  • "The Use of Antimalarial Drugs against Viral Infection," 2020, Microorganisms
  • "Design and development of plastic antibodies against SARS-CoV-2 RBD based on molecularly imprinted polymers that inhibit in vitro virus infection," 2021, Nanoscale
  • "Prosthetic joint infections and legal disputes: a threat to the future of prosthetic orthopedics," 2021, Journal of Orthopaedics and Traumatology
  • "The Obesity-Related Gut Bacterial and Viral Dysbiosis Can Impact the Risk of Colon Cancer Development," 2020, Microorganisms
  • "Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer," 2020, Frontiers in Oncology

Pasquale Ferrante frequently collaborates with several co-authors, including:

  • Serena Delbue
  • Lucia Signorini
  • Maria Dolci
  • Sarah D'Alessandro
  • Giuseppe Basile

The scientist's research has been published in a range of venues, with repeated contributions to:

  • Microorganisms
  • Journal of Orthopaedics and Traumatology
  • Nanoscale
  • Frontiers in Oncology
  • Viruses

Pasquale Ferrante's work spans across 48 identified publications in medicine, with 17 focused on infectious diseases and further involvement in oncology, epidemiology, public health, and surgery fields. The studies address clinical and molecular aspects of viral infections, cancer risks associated with microbiome changes, and the development of innovative therapeutic approaches.

Best Publications

  • Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

    Prasanta K. Dash;Rafal Kaminski;Ramona Bella;Hang Su

  • Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.

    R. Kaminski;R. Bella;C. Yin;J. Otte

  • T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV

    Mario Clerici;Marina Saresella;Fulvia Colombo;Sabrina Fossati

  • B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.

    Daria Trabattoni;Marina Saresella;Mara Biasin;Adriano Boasso

  • Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.

    Laura Calabresi;Guido Franceschini;Cesare R. Sirtori;Anna De Palma

  • Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.

    Diane V. Havlir;Matthew C. Strain;Mario Clerici;Caroline Ignacio

  • JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature

    L Vago;P Cinque;E Sala;M Nebuloni

  • The Use of Antimalarial Drugs against Viral Infection

    Sarah D’Alessandro;Diletta Scaccabarozzi;Lucia Signorini;Federica Perego

  • Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5

    Mario Clerici;Stefano Butto;Matthew Lukwiya;Marina Saresella

  • Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients.

    Livianna Speciale;Elena Calabrese;Marina Saresella;Carmine Tinelli

  • HTLV-II infection in Italian drug abusers.

    Davide Zella;Luigi Mori;Monica Sala;Pasquale Ferrante

  • Cytokine Production and Surface Marker Expression in Acute and Stable Multiple Sclerosis: Altered IL-12 Production and Augmented Signaling Lymphocytic Activation Molecule (SLAM)-Expressing Lymphocytes in Acute Multiple Sclerosis

    P Ferrante;M L Fusi;M Saresella;D Caputo

  • Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis

    Alexandre Rolland;Evelyne Jouvin-Marche;Marina Saresella;Pasquale Ferrante

  • Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.

    A. Vigano;S. Vella;M. Saresella;A. Vanzulli

  • HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis.

    C. Fusco;V. Andreone;G. Coppola;V. Luongo

  • Reactivation of JC virus and development of PML in patients with multiple sclerosis

    K. Khalili;M. K. White;F. Lublin;P. Ferrante

  • Mucosal and Systemic Immune Activation Is Present in Human Immunodeficiency Virus—Exposed Seronegative Women

    Mara Biasin;Sergio Lo Caputo;Livianna Speciale;Fulvia Colombo

  • PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy.

    Pasquale Ferrante;Rita Caldarelli-Stefano;Elisabetta Omodeo-Zorini;Luca Vago

  • Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice

    Ramona Bella;Rafal Kaminski;Pietro Mancuso;Won-Bin Young

  • Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease

    Mario Clerici;Marina Saresella;Daria Trabattoni;Livianna Speciale

  • Human alpha defensin in HIV-exposed but uninfected individuals.

    Daria Trabattoni;Sergio Lo Caputo;Giada Maffeis;Francesca Vichi

Frequent Co-Authors

Marina Saresella
Marina Saresella MRC Laboratory of Molecular Biology
Mario Clerici
Mario Clerici University of Milan
Daria Trabattoni
Daria Trabattoni University of Milan
Kamel Khalili
Kamel Khalili Temple University
Donatella Taramelli
Donatella Taramelli University of Milan
Diego Franciotta
Diego Franciotta University of Pavia
Giovanni Sotgiu
Giovanni Sotgiu University of Sassari
Valentina Bollati
Valentina Bollati University of Milan
Shohreh Amini
Shohreh Amini Temple University
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees can provide a strong foundation and diverse career opportunities. Many students consider nursing programs, which offer hands-on experience and direct patient care roles. Exploring the easiest absn programs to get into can be a practical starting point for individuals aiming to transition into nursing with an accelerated timeline.

Similarly, Licensed Practical Nurse (LPN) degrees offer a quicker entry into healthcare roles that support immunological research and patient treatment. Checking out the best easiest lpn programs to get into can help prospective students find accessible options tailored to their needs.

For advanced clinical roles, nurse practitioner programs provide opportunities to work more independently within immunology-related specialties. Identifying what is the easiest np program is key to selecting a path that balances rigor and flexibility.

Additionally, the mental health field intersects closely with immunology, especially in psychiatric mental health nurse practitioner (PMHNP) roles. Researching top pmhnp programs with strong clinical placements can enhance practical experience and career readiness.

Best Scientists Citing Pasquale Ferrante

Trending Scientists

Recently Published Articles